Chidamide Combination With Lenalidomide in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma
Clinical trial NCT04329130 · UNKNOWN
Trial details
- NCT number
- NCT04329130
- Sponsor
- Sun Yat-sen University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-27
- Primary completion
- 2022-03-26
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.